פוסטימון 150 IU ইস্রায়েল - হিব্রু - Ministry of Health

פוסטימון 150 iu

tzamal bio-pharma ltd - urofollitropin - אבקה להכנת תמיסה לזריקה - urofollitropin 150 iu/vial - urofollitropin - urofollitropin - a treatment with fsh followed by the administration of human chronic gonadotrophin (hcg) is indicated to induce ovulation in infertile women suffering from hypothalamus or hypophyseal disorders and in spanomenorrhoeic or amenorrhoeic women. these women belong to the who group ii and have generally already been treated with clomiphene citrate. most have polycystic ovarian syndrome. fsh offers good therapeutic prospects for patients whose lh:fsh ratio has to be adjusted, avoiding an exogenous supply of lh fsh may be used alone or in concomitance with human menopausal gonadotropin (hmg) in order to stimulate multiple follicular growth in patients involved in medically assisted reproduction programs (ivf-et,gift).

רקובל 12 ইস্রায়েল - হিব্রু - Ministry of Health

רקובל 12

ferring pharmaceuticals ltd - follitropin delta - תמיסה להזרקה - follitropin delta 12 mcg / 0.36 ml - follitropin delta

רקובל 36 ইস্রায়েল - হিব্রু - Ministry of Health

רקובל 36

ferring pharmaceuticals ltd - follitropin delta - תמיסה להזרקה - follitropin delta 36 mcg / 1.08 ml - follitropin delta

רקובל 72 ইস্রায়েল - হিব্রু - Ministry of Health

רקובל 72

ferring pharmaceuticals ltd - follitropin delta - תמיסה להזרקה - follitropin delta 72 mcg / 2.16 ml - follitropin delta

ברבל ইস্রায়েল - হিব্রু - Ministry of Health

ברבל

ferring pharmaceuticals ltd - urofollitrophin highly purified (hpfsh) 75 iu/vial - powder for solution for injection - urofollitropin - anovulation (including polycystis ovarian disease (pcod) in women who have been unresponsive to treatment with clomiphene citrate. controlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies (art) (e.g. in vitro fertilisation/embryo transfer (evf/et), gamete intra-fallopian transfer (gift) and intracytoplasmic sperm injection (icsi)).

אורגלוטרן 0.25 מג0.5 מל ইস্রায়েল - হিব্রু - Ministry of Health

אורגלוטרן 0.25 מג0.5 מל

organon pharma israel ltd., israel - ganirelix - תמיסה להזרקה - ganirelix 0.25 mg / 0.5 ml - ganirelix - ganirelix - the prevention of premature luteinsing hormone (lt) surges in women undergoing controlled ovarian hyperstimulation (coh) for assisted reproduction techniques (art).

נורדיטרופין 15 מג ইস্রায়েল - হিব্রু - Ministry of Health

נורדיטרופין 15 מג

novo nordisk ltd., israel - somatropin - תמיסה להזרקה - somatropin 10 mg / 1 ml - somatropin - somatropin - children: short stature due to inadequate or failed secretion of pituitary growth hormone or turner`s syndrome. short stature in children with renal insufficiency. growth disturbance (current height sds < - 2.5 and parental adjusted height sds < - 1) in short children born small for gestational age (sga) with a birth weight and/or length below - 2 sd who failed to show catch-up growth (hv sds < during the last year) by 4 years of age or later.children with short stature associated with noonan syndrome.adults: treatment of adults with hypothalamic-pituitary disease resulting from organic disease or pituitary tumors treated medically surgically or radiotherapy or patients with chilhood onset of g.h. deficiency.

נורדיטרופין 10 מג ইস্রায়েল - হিব্রু - Ministry of Health

נורדיטרופין 10 מג

novo nordisk ltd., israel - somatropin - תמיסה להזרקה - somatropin 10 mg / 1.5 ml - somatropin - somatropin - children: short stature due to inadequate or failed secretion of pituitary growth hormone or turner`s syndrome. short stature in children with renal insufficiency. growth disturbance (current height sds < - 2.5 and parental adjusted height sds < - 1) in short children born small for gestational age (sga) with a birth weight and/or length below - 2 sd who failed to show catch-up growth (hv sds < during the last year) by 4 years of age or later.children with short stature associated with noonan syndrome.adults: treatment of adults with hypothalamic-pituitary disease resulting from organic disease or pituitary tumors treated medically surgically or radiotherapy or patients with chilhood onset of g.h. deficiency.

גנוטרופין 12 מג ইস্রায়েল - হিব্রু - Ministry of Health

גנוטרופין 12 מג

pfizer pharmaceuticals israel ltd - somatropin - אבקה להכנת תמיסה לזריקה - somatropin 12 mg - somatropin - somatropin - children: short stature due to inadequate or failed secretion of pituitary growth hormone or turner`s syndrome. short stature in children with renal insufficiency. growth disturbance (height sds<2.5 and parenteral adjusted height sds < -1) in short children born sga (sga - small for gestational age i.e. born small in relation to the length of the fetus development) with a birth witght and/or length < 2 sd who failed to show catch up growth (hv sds < 0 during the last year) by 4 years of age or later. prader willi syndrome for improvement of growth and body composition. adults: for adults who have suffered from growth-hormone deficiency since childhood. for adults who have aquired growth hormone deficiency due to a pituitary pathology causing hypopituitarism.

גונאל-אף 75 יחידות בינל (5.5 מקג) ইস্রায়েল - হিব্রু - Ministry of Health

גונאל-אף 75 יחידות בינל (5.5 מקג)

merck serono ltd - follitropin alfa - אבקה להכנת תמיסה לזריקה - follitropin alfa 5.5 mcg/dose - follitropin alfa - follitropin alfa - 1) gonal-f followed by chorionic gonadotrophin (hcg) is recommended for the stimulation of follicular development and ovulation in women with hypothalamic-pituitary dysfunction who present with either oligomenorrhoea or amenorrhoea. these women are classified as w.h.o group ii patients and usually receive clomiphene citrate as primary therapy. they have evidence of endogenous oestrogen production and thus will either spontaneously menstruate or experience withdrawal bleeding after progestagen administration. polycystic ovarian disease (pcod) is part of the who ii classification and is present in the majority of these patients. 2) gonal-f is indicated for stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertillization (ivf) gamete intra-fallopian transfer (gift) and zogote intra-fallopian transfer (zift). 3) gonal-f is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of sperma